Mantidan


Indications and Reactions:

Role Indications Reactions
Secondary
Parkinson's Disease 40.0%
Product Used For Unknown Indication 26.7%
Rheumatoid Arthritis 13.3%
Hypertonic Bladder 6.7%
Prostatomegaly 6.7%
Tremor 6.7%
Interstitial Lung Disease 33.3%
Tachycardia 33.3%
Weight Decreased 33.3%
Concomitant
Product Used For Unknown Indication 32.8%
Relapsing-remitting Multiple Sclerosis 13.3%
Parkinson's Disease 13.1%
Multiple Sclerosis 5.6%
Depression 3.2%
Hypertension 3.2%
Dementia Alzheimer's Type 3.0%
Secondary Progressive Multiple Sclerosis 3.0%
Sleep Disorder Therapy 3.0%
Gait Disturbance 2.4%
Osteoporosis 2.4%
Pain In Extremity 2.2%
Paraesthesia 2.2%
Premedication 2.0%
Bronchopneumonia 1.6%
Headache 1.6%
Insomnia 1.6%
Diabetes Mellitus 1.4%
Muscle Relaxant Therapy 1.4%
Fatigue 1.2%
Urinary Tract Infection 16.9%
Muscular Weakness 9.1%
Multiple Sclerosis Relapse 6.5%
Vision Blurred 6.5%
Arthralgia 5.2%
Asthenia 5.2%
Fatigue 5.2%
Weight Decreased 5.2%
Yellow Skin 5.2%
Arrhythmia 3.9%
Gait Disturbance 3.9%
Haematemesis 3.9%
Pain 3.9%
Somnolence 3.9%
Central Nervous System Lesion 2.6%
Diabetes Mellitus 2.6%
Diarrhoea 2.6%
Ectopic Pregnancy 2.6%
Emotional Disorder 2.6%
Infection 2.6%

Drug Data